PubMed · 3111252
Should platelets be radiolabelled in plasma medium?
Abstract
Because of the low labelling efficiency of platelets with In-111 oxine in plasma containing media, most investigators have labelled platelets in plasma-free media. However, labelling of platelets with In-111 oxine in plasma-free media may result in either: irreversible damage leading to rapid clearance from the circulation and permanent hepatic sequestration; or reversible damage with transient hepatic sequestration without affecting the in vivo survival. Since human platelets can be labelled with In-111 oxine in plasma in sufficient efficiency for routine clinical use, they should be labelled in plasma whenever possible. The use of newer In-111 chelates, tropolone and mercaptopyridine-N-oxide, which label platelets with high efficiency in plasma as well as in plasma-free media, may offer another alternative.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
M F Tsan, R L Hill-Zobel. 1987. Should platelets be radiolabelled in plasma medium?. https://doi.org/10.1002/ajh.2830250318
Cite the original work for its findings. Save a collection to share your selection of sources.